Skip to main content
. 2016 Apr 21;7(22):33165–33178. doi: 10.18632/oncotarget.8890

Table 2. Hazard ratio for death of patients in baseline of JBR.10.

Univariate analysis Multivariate analysis
HR 95 % CI p-value HR 95% CI p-value
Age
 <65/≥65 1.839 1.101-3.071 0.0198 1.89 1.131-3.157 0.0151
Sex
 Female/male 0.617 0.339-1.236 0.1145
Stage of disease
 IB/II 1.734 1.042-2.884 0.0341 1.782 1.070-2.967 0.0263
Pahological subtype
 Non-SCC/SCC 0.620 0.359-1.069 0.0856
Expression of ACTN4
 Positive/negative 1.036 0.588-1.994 0.9143
Treatment recived
 Observation alone / adjuvant chemotherapy 0.796 0.479-1.321 0.3771

The clinical data was according to refernce **. HR; hazard ratio, CI, confidatial interval, SCC: squamouse cell carcinoma.